Moussa B. H. Youdim And Notquantitative real‐time PCR
List of bibliographic references
Number of relevant bibliographic references: 9.Ident. | Authors (with country if any) | Title |
---|---|---|
001036 | Orly Weinreb [Israël] ; Tamar Amit [Israël] ; Orit Bar-Am [Israël] ; Moussa B. H. Youdim [Israël] | Induction of Neurotrophic Factors GDNF and BDNF Associated with the Mechanism of Neurorescue Action of Rasagiline and Ladostigil |
001178 | Moussa B. H. Youdim [Israël] ; Dale Edmondson [États-Unis] ; Keith F. Tipton [Irlande (pays)] | The therapeutic potential of monoamine oxidase inhibitors |
001197 | Anna L. Bartels [Pays-Bas] ; Bauke M. De Jong [Pays-Bas] ; Nir Giladi [Israël] ; Joanna D. Schaafsma [Pays-Bas] ; R. Paul Maguire [Pays-Bas] ; Lammy Veenma [Pays-Bas] ; Jan Pruim [Pays-Bas] ; Yacov Balash [Israël] ; Moussa B. H. Youdim [Israël] ; Klaus L. Leenders [Pays-Bas] | Striatal dopa and glucose metabolism in PD patients with freezing of gait |
001436 | Moussa B. H. Youdim [Israël] ; Orit Bar Am [Israël] ; Merav Yogev-Falach [Israël] ; Orly Weinreb [Israël] ; Wakako Maruyama [Japon] ; Makato Naoi [Japon] ; Tamar Amit [Israël] | Rasagiline: Neurodegeneration, neuroprotection, and mitochondrial permeability transition |
001453 | Orly Weinreb [Israël] ; Tamar Amit [Israël] ; Orit Bar-Am [Israël] ; Orly Chillag-Talmor [Israël] ; Moussa B. H. Youdim [Israël] | Novel Neuroprotective Mechanism of Action of Rasagiline Is Associated with Its Propargyl Moiety: Interaction of Bcl‐2 Family Members with PKC Pathway |
001616 | Moussa B. H. Youdim [Israël] ; Galia Stephenson [Israël] ; Dorit Ben Shachar [Israël] | Ironing Iron Out in Parkinson's Disease and Other Neurodegenerative Diseases with Iron Chelators: A Lesson from 6‐Hydroxydopamine and Iron Chelators, Desferal and VK‐28 |
001617 | Luigi Zecca [Italie] ; Moussa B. H. Youdim [Israël] ; Peter Riederer [Allemagne] ; James R. Connor [États-Unis] ; Robert R. Crichton [Belgique] | Iron, brain ageing and neurodegenerative disorders |
001A10 | Moussa B. H. Youdim [Israël] ; A. Wadia [États-Unis] ; W. Tatton [États-Unis] ; Marta Weinstock [Israël] | The Anti‐Parkinson Drug Rasagiline and Its Cholinesterase Inhibitor Derivatives Exert Neuroprotection Unrelated to MAO Inhibition in Cell Culture and in Vivo |
002665 | Manfred Gerlach [Allemagne] ; Peter Riederer [Allemagne] ; Horst Przuntek [Allemagne] ; Moussa B. H. Youdim [Israël] | MPTP mechanisms of neurotoxicity and their implications for Parkinson's disease |
This area was generated with Dilib version V0.6.23. |